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REPLY
We appreciate the supportive data provided by Van Norman and
Posner regarding an enhanced risk in these patients with coronary
artery disease who underwent percutaneous transluminal coronary
angioplasty (PTCA) prior to noncardiac surgery (NCS). In con-
trast to the study cited in their letter (1), our study (2) covered a
later time period (1996 to 1998) and included only patients who
had undergone coronary stent implantation within six weeks of
NCS. Although our conclusions are similar, that there is a
paradoxical increase in risk, we found this risk to be demonstrated
only in those patients whose NCS occurred within two weeks of
stent implantation.
Hence, their suggestion that NCS be postponed 40 to 90 days
after coronary intervention may not be applicable to stented
patients.
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Reduced Global Myocardial Thallium
Uptake—An Important Marker of Severe
Coronary Artery Disease
We read with interest the study by Kwok et al. (1). Their study
examines a cohort of patients with a single abnormal territory on
thallium perfusion imaging, but in whom 26% are shown to have
severe three-vessel or left main disease (3VLMD) on angiography.
The authors present the clinical concern that individuals with a
single territory defect rather than those with multiterritory disease
will be less likely to be referred for angiography and therefore be
denied potential revascularization and improved long-term out-
come.
The report, therefore, highlights the importance of clinical and
exercise variables for identifying 3VLMD, and the results would
support the rationale for performing perfusion imaging with
exercise stress rather than pharmacologic methods wherever pos-
sible.
Regarding the thallium imaging itself, however, an important
radionuclide marker of severe disease that would have strongly
affected the model was not employed. It is accepted that insuffi-
cient stress or the presence of collateral blood supplies may produce
small defects. Of more concern is whether severe 3VLMD limits
the flow to all territories, thereby reducing global myocardial
thallium uptake. Two possibilities may result: either one artery will
harbor the most critical lesion, thereby producing a single territory
perfusion defect relative to the other abnormal territories, or rarely,
an apparently normal scan may be produced due to perfectly
symmetrical, proximal three-vessel disease. To identify these
possibilities, a simple estimate of global myocardial thallium
uptake can be the discriminatory factor (2). Rather than simply
comparing myocardial and lung thallium uptake, a ratio of left
ventricular thallium counts (minus background region) compared
with administered injection dose (calculated as the difference
between presyringe and postsyringe counts over 10 s) could be
expressed. This method in a group of 90 patients undergoing
diagnostic coronary angiography increases sensitivity for detecting
three-vessel disease from 77% with perfusion scoring alone to 95%
with the myocardial uptake score included, with no reduction in
specificity (3). In a concluding remark, the authors also express
enthusiasm for future ECG gating of images. We have demon-
strated that this will notably increase sensitivity and specificity for
patients with coronary disease (4).
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REPLY
We appreciate the interest by Keeble et al. in our study concerning
T1-201 scintigraphic abnormalities in patients with severe coro-
nary artery disease (CAD) (1). Certainly inadequate exercise is a
potential cause for limited perfusion abnormalities in patients with
severe disease, because the development of blood flow heteroge-
neity is restricted. We doubt that the method proposed by Keeble
et al. in estimating global thallium uptake would alter our findings
(2,3). The ratio of left ventricular thallium activity to injected
thallium-201 counts in the syringe will offer little new data,
because the injected dose for all patients was the same (4 mCi).
More importantly, the impact of individual body configuration on
gamma camera photon detection for thallium-201 is large. We
have previously shown (4) that detected thallium activity varies
threefold to fourfold in normal myocardium even in patients of
similar weight (and therefore cannot be confidently estimated). It
is this factor (among others) that precludes estimates of absolute
myocardial blood flow with conventional radionuclide techniques.
The article by Keeble et al. showed a two-fold variability in normal
volunteers for their method of estimation of global thallium-201
uptake (2). Perhaps the method proposed was helpful in improving
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